Li X, Benjamin I S, Alexander B
Department of Surgery, King's College School of Medicine and Dentistry, Rayne Institute, London, UK.
Gut. 1998 Feb;42(2):276-82. doi: 10.1136/gut.42.2.276.
Portal hypertension is associated with gross haemodynamic disturbances characterised by high cardiac output, low peripheral vascular resistance, increased splanchnic blood flow, and portal systemic shunting.
To study the relationship between intrahepatic portal systemic shunts and microsphere induced portal hypertension in the rat liver.
Different sized microspheres were sequentially injected into the portal vein of male Wistar rats.
Steady state portal venous pressure was increased by 102.2 (35.6)% (14.9 (3.6) mm Hg) and 272.3 (78.0)% (24.0 (2.2) mm Hg) above the basal pressure following sequential injections of 15 and 80 microns diameter microspheres, respectively. Sequential injection of 15, 40, and 80 microns diameter microspheres in either ascending or descending order of size did not generate further increases in portal venous pressure. A single injection of 1.8 x 10(5) 80 microns microspheres consistently produced a steady state portal venous pressure of 19.0 (1.3) mm Hg but did not approach the much higher value of 36.6 (43.2) mm Hg measured during clamping of the portal vein. These data indicate that the opening of patent intrahepatic shunts was responsible for the reduced pressures observed during microsphere injections and further evidence for this was provided by the location of microspheres in the pulmonary vascular bed. The elevation in portal venous pressure achieved by microsphere injections was not significantly different to that produced in rats subjected to partial portal vein ligation (20.7 (0.5) mm Hg, p > 0.05). Wedged hepatic venous pressure decreased from 6.7 (0.7) to 3.0 (0.6) mm Hg following injection of 80 microns microspheres, suggesting a decrease in total hepatic blood flow. Conversely, injection of 15 microns microspheres induced an increase in wedged hepatic venous pressure from 7.0 (1.0) mm Hg to 12.4 (1.8) mm Hg, indicating a localised redistribution of blood flow at the presinusoidal level of the portal venous vascular network and increased intrahepatic shunt flow.
It is suggested that there may be a protective pathophysiological role for these shunts when the liver is subjected to changes which induce acute portal hypertension.
门静脉高压与严重的血流动力学紊乱相关,其特征为高心输出量、低外周血管阻力、内脏血流增加以及门体分流。
研究大鼠肝脏内肝内门体分流与微球诱导的门静脉高压之间的关系。
将不同大小的微球依次注入雄性Wistar大鼠的门静脉。
依次注射直径为15微米和80微米的微球后,稳态门静脉压力分别比基础压力升高了102.2(35.6)%(14.9(3.6)毫米汞柱)和272.3(78.0)%(24.0(2.2)毫米汞柱)。按大小升序或降序依次注射直径为15、40和80微米的微球,门静脉压力未进一步升高。单次注射1.8×10⁵个80微米的微球始终产生19.0(1.3)毫米汞柱的稳态门静脉压力,但未达到门静脉夹闭时测得的36.6(43.2)毫米汞柱的高得多的值。这些数据表明,肝内开放的分流导致了微球注射期间观察到的压力降低,微球在肺血管床中的位置为此提供了进一步证据。微球注射导致的门静脉压力升高与部分门静脉结扎大鼠产生的压力升高无显著差异(20.7(0.5)毫米汞柱,p>0.05)。注射80微米微球后,肝静脉楔压从6.7(0.7)毫米汞柱降至3.0(0.6)毫米汞柱,提示肝总血流量减少。相反,注射15微米微球导致肝静脉楔压从7.0(1.0)毫米汞柱升至12.4(1.8)毫米汞柱,表明门静脉血管网络窦前水平的血流出现局部重新分布,肝内分流流量增加。
提示当肝脏受到诱导急性门静脉高压的变化影响时,这些分流可能具有保护性病理生理作用。